X
Search
X

Patient Support Hotline

Call (844) 244-1309

ZERO360 is a free, comprehensive patient support service to help patients and their families navigate insurance and financial obstacles to cover treatment and other critical needs associated with cancer.

X

Subscribe to our E-Newsletter

Stay up-to-date on the latest news about prostate cancer. Join our distribution list to receive periodic email updates and our monthly e-newsletter.

  • Patient Support (844) 244-1309
  • Search
  • e-News Signup Enews Signup
  • Run/Walk
  • Donate

Alicia Morgans, MD, on Treatment Options for Metastatic Castration-Sensitive Prostate Cancer

Advances in upfront hormonal and chemohormonal therapy have driven a dramatic shift in treatment paradigms for metastatic castration-sensitive prostate cancer (mCSPC). At the same time, ongoing controversy around prostate-specific antigen screening practices, increased access to novel imaging modalities, and a globally aging population are driving increasing rates of this disease.

Read the full article here.

source: Jeff Minerd - Medpage Today